Evogene

📍 Rehovot, Israel🗓 Founded 2002👥 117 employees💰 Last funded Aug 2016
Biotechnology Research🌐 evogene.com
Website LinkedIn
Evogene (NASDAQ, TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd. For more information, please visit www.evogene.com
2
Total investors
0
Early stage
1
Mid stage
0
Late stage
2002
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Evogene?
Evogene has 2 investors on record on gritt.io, 1 mid-stage.
When did Evogene last raise funding?
The most recent investment in Evogene recorded on gritt.io was in August 2016.
When was Evogene founded?
Evogene was founded in 2002.
What industry is Evogene in?
Evogene operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Evogene based?
Evogene is headquartered in Rehovot, Israel.